Assembly Bill A7219A

2017-2018 Legislative Session

Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee

  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

Bill Amendments

2017-A7219 - Details

See Senate Version of this Bill:
S2489
Current Committee:
Assembly Higher Education
Law Section:
Education Law
Laws Affected:
Amd §6816-a, Ed L
Versions Introduced in Other Legislative Sessions:
2015-2016: S8189
2019-2020: A1181, S3539
2021-2022: A3981, S6393
2023-2024: A6988, S4447

2017-A7219 - Summary

Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.

2017-A7219 - Bill Text download pdf 

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   7219
 
                        2017-2018 Regular Sessions
 
                           I N  A S S E M B L Y
 
                              April 12, 2017
                                ___________
 
 Introduced by M. of A. ABINANTI -- read once and referred to the Commit-
   tee on Higher Education
 
 AN  ACT  to  amend the education law, in relation to the substitution of
   brand name epinephrine autoinjectors with generic epinephrine  autoin-
   jectors for dispensation by pharmacists

   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Section 6816-a of the education law is amended by adding  a
 new subdivision 3 to read as follows:
   3.  (A)  NOTWITHSTANDING  SUBDIVISION TWO OF THIS SECTION OR ANY OTHER
 SECTION OF LAW TO THE CONTRARY, WHEN A PATIENT  IS  PRESCRIBED  A  BRAND
 NAME  EPINEPHRINE  AUTOINJECTOR,  A  PHARMACIST MAY SUBSTITUTE A GENERIC
 EPINEPHRINE AUTOINJECTOR CONTAINING THE SAME ACTIVE INGREDIENTS,  DOSAGE
 FORM  AND  STRENGTH  AS  THE  BRAND  NAME PRODUCT PRESCRIBED, ORDERED OR
 DEMANDED, PROVIDED THAT THE PRESCRIBER DOES NOT PROHIBIT SUBSTITUTION.
   (B) FOR PURPOSES OF THIS SUBDIVISION "EPINEPHRINE AUTOINJECTOR"  MEANS
 A  MEDICAL  DEVICE FOR INJECTING A MEASURED DOSE OR DOSES OF EPINEPHRINE
 (ADRENALINE) BY MEANS OF AUTOINJECTOR TECHNOLOGY.
   § 2. This act shall take effect immediately.
 
 
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD04490-01-7

co-Sponsors

multi-Sponsors

2017-A7219A (ACTIVE) - Details

See Senate Version of this Bill:
S2489
Current Committee:
Assembly Higher Education
Law Section:
Education Law
Laws Affected:
Amd §6816-a, Ed L
Versions Introduced in Other Legislative Sessions:
2015-2016: S8189
2019-2020: A1181, S3539
2021-2022: A3981, S6393
2023-2024: A6988, S4447

2017-A7219A (ACTIVE) - Summary

Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.

2017-A7219A (ACTIVE) - Bill Text download pdf 

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  7219--A
 
                        2017-2018 Regular Sessions
 
                           I N  A S S E M B L Y
 
                              April 12, 2017
                                ___________
 
 Introduced by M. of A. ABINANTI -- read once and referred to the Commit-
   tee on Higher Education -- committee discharged, bill amended, ordered
   reprinted as amended and recommitted to said committee
 
 AN  ACT  to  amend the education law, in relation to the substitution of
   brand name epinephrine auto-injectors with alternate epinephrine auto-
   injectors for dispensation by pharmacists
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1. Section 6816-a of the education law is amended by adding a
 new subdivision 3 to read as follows:
   3. (A) NOTWITHSTANDING SUBDIVISION TWO OF THIS SECTION  OR  ANY  OTHER
 SECTION  OF  LAW  TO  THE CONTRARY, WHEN A PATIENT IS PRESCRIBED A BRAND
 NAME EPINEPHRINE AUTO-INJECTOR, A PHARMACIST MAY SUBSTITUTE AN ALTERNATE
 EPINEPHRINE AUTO-INJECTOR CONTAINING THE SAME ACTIVE INGREDIENTS, DOSAGE
 FORM AND STRENGTH AS THE  BRAND  NAME  PRODUCT  PRESCRIBED,  ORDERED  OR
 DEMANDED,  REGARDLESS OF WHETHER THE ALTERNATE EPINEPHRINE AUTO-INJECTOR
 IS INCLUDED IN THE LATEST LIST OF INTERCHANGEABLE DRUG PRODUCTS FOR  THE
 PRESCRIBED EPINEPHRINE AUTO-INJECTOR DEVICE, PROVIDED THAT:
   (I)  THE  PRESCRIBER  DOES NOT INDICATE THAT THE PRESCRIPTION THEREFOR
 SHALL BE DISPENSED AS WRITTEN PURSUANT TO PARAGRAPH (A)  OF  SUBDIVISION
 SIX OF SECTION SIXTY-EIGHT HUNDRED TEN OF THIS ARTICLE;
   (II) THE ALTERNATE EPINEPHRINE AUTO-INJECTOR AVAILABLE WOULD REFLECT A
 LOWER UNIT COST TO THE PURCHASER; AND
   (III)  THE PHARMACIST HAS ADVISED THE PURCHASER OF THE AVAILABILITY OF
 AN ALTERNATE EPINEPHRINE AUTO-INJECTOR AND OBTAINED CONSENT TO  DISPENSE
 THE ALTERNATE EPINEPHRINE AUTO-INJECTOR.
   (B) FOR PURPOSES OF THIS SUBDIVISION "EPINEPHRINE AUTO-INJECTOR" SHALL
 HAVE THE SAME MEANING AS PROVIDED IN PARAGRAPH (B) OF SUBDIVISION ONE OF
 SECTION THREE THOUSAND-C OF THE PUBLIC HEALTH LAW.
   § 2. This act shall take effect immediately.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD04490-03-7

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.